By Professor Caroline Ford

Journal articles

Ford CE, 1972, 'Temperature measurement and distribution in Tuttle hydrothermal pressure vessels', Measurement Science and Technology, 5, pp. 457, http://dx.doi.org/10.1088/0022-3735/5/5/024

Conference Papers

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, BMJ PUBLISHING GROUP, pp. A32 - A33, http://dx.doi.org/10.1136/ijgc-2023-IGCS.47

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045, http://dx.doi.org/10.1158/1538-7445.am2021-1045

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Kobel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. po042 - po042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. a41 - a41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2020, 'Abstract B28: Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. b28 - b28, http://dx.doi.org/10.1158/1557-3265.ovca19-b28

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2019, 'Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, pp. 93 - 93, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Henry CE; Hacker NF; Ford CE, 2018, 'Abstract 106: Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. 106 - 106, http://dx.doi.org/10.1158/1538-7445.am2018-106

Henry CE; Llamosas E; Hacker NF; Heinzelmann-Schwarz V; Ford CE, 2016, 'Abstract 1636: The role of the ROR receptors in ovarian cancer progression and chemoresistance', in Cancer Research, American Association for Cancer Research (AACR), pp. 1636 - 1636, http://dx.doi.org/10.1158/1538-7445.am2016-1636

Ford CE; Tuomela J; Hedditch EL; Axelsson L; Liu Q; Ward RL; Härkönen P; Andersson T, 2010, '43 Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', in European Journal of Cancer Supplements, Elsevier, pp. 11, http://dx.doi.org/10.1016/s1359-6349(10)70852-1

Kennedy S; Waliuzzaman Z; Ford C; Rawlinson W; Pussell B, 2005, 'Recurrent HUS following kidney transplant possibly precipitated by CMV', in IMMUNOLOGY AND CELL BIOLOGY, BLACKWELL PUBLISHING, AUSTRALIA, Canberra, pp. A16 - A17, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, Canberra, 11 May 2005 - 13 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Chisholm OT; Gomes L; Thai T; Nixdorf S; Williams R; Clayphan A; Vigentini L; Zhang C; Zhao L; King M; Ford C, (ed.), 2016, 'Empowering Online Learners Using Assessment and Feedback', UNSW, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016

Conference Presentations

Nixdorf S; Chisholm OT; Gomes L; Ford C, 2016, 'Student Engagement in the Personalised Medicine MOOC: Does the Learning Platform Matter?', presented at UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, 07 December 2016 - 07 December 2016

Ford C; Chisholm O; Gomes L, 2016, 'The Hope and Hype of the Genetic Revolution: Reflections on UNSW Medicine's First MOOC', presented at Connections Seminar Series, UNSW Australia, UNSW Australia, 19 May 2016 - 19 May 2016

Ford C; Chisholm OT; Gomes L, 2015, 'Hope and Hype: Reflections on UNSW Medicine's First MOOC', presented at 2015 UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, NSW, Australia, 02 December 2015 - 02 December 2015, https://med.unsw.edu.au/annual-learning-and-teaching-forum

Chisholm O; Nixdorf S; Williams R; Ford C, 2014, 'Reflections on the development of an open online course', presented at UNSW Medicine Learning and Teaching Forum 2014, UNSW Australia, 10 December 2014 - 10 December 2014, http://med.unsw.edu.au/annual-learning-and-teaching-forum

Ford C, 2014, 'Hear the Ror! The role of Wnt signalling in ovarian cancer.', presented at International Society for Gynecologic Cancers, Melbourne, 08 November 2014 - 11 April 2015

Ford CE; Henry CE; Llamosas E; Djordjevic A; Hacker NF; Heinzelmann-Schwarz VA; Ward RL, 2014, 'HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER'

Conference Abstracts

Macdonald ER; Rose G; Simar D; McCarthy AL; Ford C; Warton K; Hayes S; Clifford BK, 2026, 'Evaluating the utility of circulating cell-free DNA in the context of endometrial cancer: a systematic scoping review', in International Journal of Gynecological Cancer, Vol. 36, http://dx.doi.org/10.1016/j.ijgc.2026.104767

Madani D; Satgunaseelan L; El-Hayek J; Shivalingam B; Ford C, 2024, 'ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER', in Neuro-Oncology, Oxford University Press (OUP), Vol. 26, pp. vii4 - vii5, http://dx.doi.org/10.1093/neuonc/noae158.016

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, 'Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Journal of Clinical Oncology, American Society of Clinical Oncology, Vol. 42, presented at 2024 ASCO Annual Meeting, 29 May 2024 - 29 May 2024, http://dx.doi.org/10.1200/JCO.2024.42.16_suppl.5547

Phan Z; Ford CE; Caldon E, 2024, 'Abstract A115: DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a115 - a115, http://dx.doi.org/10.1158/1538-7445.ovarian23-a115

Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2024, 'Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 30, pp. b014 - b014, http://dx.doi.org/10.1158/1557-3265.endo24-b014

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'Abstract 2942: ROR1: A novel target in endometrial cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 80, pp. 2942 - 2942, http://dx.doi.org/10.1158/1538-7445.am2020-2942

Yuwono NL; Warton K; Henry C; Ford C, 2020, 'Abstract 731: Deciphering the origin of circulating cell-free DNA and its alterations during menstruation', in Cancer Research, American Association for Cancer Research (AACR), Vol. 80, pp. 731 - 731, http://dx.doi.org/10.1158/1538-7445.am2020-731

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Media

Ford C; Chisholm O, 2015, Brace yourself genetic testing might give you more than you bargained for., https://theconversation.com/brace-yourself-genetic-testing-might-give-you-more-than-you-bargained-for-40246

Preprints

Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford CE, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford CE, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, http://dx.doi.org/10.1101/2024.03.09.24303840

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford CE, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212

Phan Z; Ford CE; Caldon CE, DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: a meta-analysis and systematic review, http://dx.doi.org/10.1101/2023.05.24.23290442

Matthews B; Wong-Brown M; Liu D; Yee C; Dickson K-A; Schneider J; Islam S; Head R; Martin J; Ford C; Marsh D; Bowden N, Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer, http://dx.doi.org/10.22541/au.169580899.90269470/v1

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, http://dx.doi.org/10.1101/2023.05.17.541071

John M; Ford C, Pan-tissue and -cancer analysis of ROR1 and ROR2 transcript variants identify novel functional significance for an alternative splice variant of ROR1, http://dx.doi.org/10.1101/2021.11.24.469652

John M; Rao P; Noor H; Ford C, ROR1 is a novel putative druggable target for diffuse glioma, http://dx.doi.org/10.1101/2021.12.03.21267166

Back to profile page